Open menu

RSS Subscribe to our Nanotechnology Business News feed

Starpharma Reports Positive VivaGel Clinical Study Results

Starpharma Holdings Limited today announced positive results of a clinical trial that achieved all its objectives demonstrating that 3% SPL7013 Gel (VivaGel) was safe and well-tolerated in sexually abstinent women when administered vaginally, twice daily for 14 days.

Posted: May 12th, 2008

Read more